Combination well-tolerated in patients with type 2 diabetes…. Ipragliflozin is an oral medication in development by Astellas Pharma for the treatment of type 2 diabetes. A novel selective sodium glucose co-transporter-2 (SGLT-2) inhibitor, ipragliflozin works similarly to the first in class marketed SGLT-2 inhibitor drug canagliflozin by increasing urinary excretion …
Read More »Metformin May Improve Survival Rates in Patients with Both Cancer and T2DM
Drug has demonstrated direct antitumor activity in mouse models….
Read More »Study Indicates that Diabetes Medication Reduced CVD Hazard Rate 53% in Type 2 Diabetes Subjects Taking Metformin
Metformin plus Cycloset shows significant CVD risk reduction for type 2 diabetes patients in trial….
Read More »Metformin’s Impact on the Heart Differs in Men and Women
Study showed positive impact for women with type 2 diabetes but….
Read More »New Research into the Mechanism of Action of Metformin
Fatty liver disease patients may react differently to metformin than those without the disease….
Read More »Use of Metformin in Gestational Diabetes
Metformin is associated with improved treatment satisfaction and a favorable impact on quality of life (QoL) compared with insulin alone or in combination…. The rise in obesity and the increasing age of mothers have contributed to an increasing incidence of GDM. Depending on the diagnostic criteria used, GDM complicates up …
Read More »Metformin and Colorectal Cancer Incidence
The intake of metformin has been associated with a decreased incidence of colorectal cancer in patients with type 2 diabetes in several studies but….
Read More »Metformin Associated with Cognitive Impairment
Individuals taking metformin and who have a vitamin B12 deficiency are associated with an impaired cognitive performance….
Read More »Metformin Yields Better Outcomes than Insulin for Gestational Diabetes
Women with gestational diabetes are more likely to control their blood glucose levels when receiving treatment with metformin rather than insulin…
Read More »Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes
This study systemically reviewed randomized controlled trials and observational studies to evaluate whether actual exposure of metformin can be associated with cancer and cancer mortality in type 2 diabetes patients….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.